XML 23 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2024
Dec. 31, 2023
Current assets:    
Cash and cash equivalents $ 185 $ 127
Marketable securities 810 632
Receivable from collaboration partners ($21 and $20 from a related party) 35 38
Prepaid expenses and other current assets 34 34
Total current assets 1,064 831
Long-term marketable securities 100 107
Property and equipment, net 51 51
Other noncurrent assets ($— and $6 from a related party) 78 106
Total assets 1,293 1,095
Current liabilities:    
Accounts payable 16 17
Deferred revenue ($112 and $84 to a related party) 124 91
Other current liabilities 64 76
Total current liabilities 204 184
Deferred revenue, noncurrent ($209 and $291 to a related party) 242 307
Other noncurrent liabilities 140 142
Commitments
Stockholders’ equity:    
Common stock and additional paid-in capital: $0.0001 par value per share; 400.0 shares authorized; 90.9 shares in 2024 and 75.5 shares in 2023 issued and outstanding 1,561 1,311
Accumulated deficit (853) (849)
Accumulated other comprehensive loss (1) 0
Total stockholders’ equity 707 462
Total liabilities and stockholders’ equity $ 1,293 $ 1,095